SCHEMBL8688772

SCHEMBL8688772

CCCCCNCCc1ccc(-c2c[nH]nn2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 4/20 0.51
▸ HRH4 Q9H3N8 1/20 0.45
▸ HRH3 Q9Y5N1 1/20 0.45
▸ S1PR2 O95136 4/20 0.42
▸ S1PR1 P21453 4/20 0.42
▸ S1PR3 Q99500 4/20 0.42
▸ S1PR4 O95977 2/20 0.42
▸ MAPT P10636 2/20 0.40
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ SLC2A1 P11166 1/20 0.39
▸ LMNA P02545 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ RAB9A P51151 3/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ CASP3 P42574 1/20 0.36
▸ SENP8 Q96LD8 1/20 0.36
▸ SENP7 Q9BQF6 1/20 0.36
▸ SENP6 Q9GZR1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5612800 0.84 RAB9A (0.49) MAPTSMN1; SMN2RAB9AL3MBTL1CASP3
SCHEMBL21274654 0.80 TAAR1 (0.49) SIGMAR1MAPTCYP1A2LMNASMN1; SMN2
SCHEMBL8689397 0.80 SIGMAR1 (0.53) SIGMAR1HRH4HRH3S1PR2S1PR1
SCHEMBL8688775 0.76 SIGMAR1 (0.46) SIGMAR1CYP2D6SLC2A1
SCHEMBL5613119 0.74 TP53 (0.49) MAPTLMNASMN1; SMN2RAB9ANPC1
SCHEMBL28732240 0.73 TP53 (0.47) MAPTLMNASMN1; SMN2RAB9ANPC1
SCHEMBL8687024 0.73 MTOR (0.42) MAPTCYP2D6SMN1; SMN2
SCHEMBL21274684 0.72 TP53 (0.43) MAPTLMNASMN1; SMN2
SCHEMBL4724249 0.72 CYP19A1 (0.56) MAPTCYP1A2CYP2D6CYP2C19LMNA
SCHEMBL21274673 0.71 AKT2 (0.46) CYP1A2CYP2C19L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5807860-A ACYLCOENZYME A:CHOLESTEROL ACYLTRANSFERASE INHIBITORS; HYPERLIPEMIA, ATHEROSCLEROSIS; ANTICHOLESTEROL AGENTS MITSUBISHI CHEMICAL CORPORATION (JP) 1998-09-15 — — US disclosed
EP-0773218-A1 N-(Piperazinylalkoxyphenyl)-N'phenylalkylurea derivatives as ACAT inhibitors for the treatment of atheroschlerosis MITSUBISHI CHEMICAL CORPORATION (JP) 1997-05-14 — — EP disclosed
Send feedback